175 related articles for article (PubMed ID: 7760052)
1. Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain.
Khawaja X; Evans N; Reilly Y; Ennis C; Minchin MC
J Neurochem; 1995 Jun; 64(6):2716-26. PubMed ID: 7760052
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
3. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
4. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.
Palego L; Marazziti D; Rotondo A; Batistini A; Lucacchini A; Naccarato AG; Bevilacqua G; Borsini F; Ladinsky H; Cassano GB
Neurochem Int; 1997 Feb; 30(2):149-57. PubMed ID: 9017662
[TBL] [Abstract][Full Text] [Related]
5. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
6. Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist.
Khawaja X
Brain Res; 1995 Mar; 673(2):217-25. PubMed ID: 7606435
[TBL] [Abstract][Full Text] [Related]
7. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Emerit MB; Miquel MC; Gozlan H; Hamon M
J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
[TBL] [Abstract][Full Text] [Related]
8. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
Burnet PW; Eastwood SL; Harrison PJ
Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain.
Hume SP; Ashworth S; Opacka-Juffry J; Ahier RG; Lammertsma AA; Pike VW; Cliffe IA; Fletcher A; White AC
Eur J Pharmacol; 1994 Dec; 271(2-3):515-23. PubMed ID: 7705452
[TBL] [Abstract][Full Text] [Related]
10. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
[TBL] [Abstract][Full Text] [Related]
12. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
Laporte AM; Lima L; Gozlan H; Hamon M
Eur J Pharmacol; 1994 Dec; 271(2-3):505-14. PubMed ID: 7705451
[TBL] [Abstract][Full Text] [Related]
13. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
Newman-Tancredi A; Chaput C; Verrièle L; Millan MJ
Eur J Pharmacol; 1996 Jun; 307(1):107-11. PubMed ID: 8831111
[TBL] [Abstract][Full Text] [Related]
14. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A
Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121
[TBL] [Abstract][Full Text] [Related]
15. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
Newman-Tancredi A; Verrièle L; Millan MJ
Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
[TBL] [Abstract][Full Text] [Related]
17. Metal ion and guanine nucleotide modulations of agonist interaction in G-protein-coupled serotonin1A receptors from bovine hippocampus.
Harikumar KG; Chattopadhyay A
Cell Mol Neurobiol; 1998 Oct; 18(5):535-53. PubMed ID: 9777253
[TBL] [Abstract][Full Text] [Related]
18. Resolution of multiple affinity states of 5-hydroxytryptamine-1A receptors labelled by [3H]-8-hydroxy-2-(di-n-propilamino) tetralin in rat hippocampal membranes.
Pesce G; Hery F
Gen Pharmacol; 1996 Jun; 27(4):723-9. PubMed ID: 8853311
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
Alper RH; Nelson DL
Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
[TBL] [Abstract][Full Text] [Related]
20. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
